The S&P 500 Just Did Something It Has Never Done Before. Wall Street Says the Stock Market Will Move Higher This Year.
https://www.fool.com/investing/2024/02/18/sp-500-never-done-before-stock-market-move-higher/?source=iedfolrf0000001
Feb 18, 2024 - The S&P 500 recently surpassed 5,000 points for the first time in history, but Wall Street analysts see more upside this year.
0
If You Like (Special) Dividends, You Will Love CME Group
https://seekingalpha.com/article/4656662-if-you-like-special-dividends-you-will-love-cme-group?source=feed
Dec 08, 2023 - CME Group demonstrates strong earnings, resilience in market volatility, and attractive dividends, making it appealing. Click for more on CME prospects.
0
If the Fed Lowers Interest Rates in 2024, This Warren Buffett Stock Could Win Big
https://www.fool.com/investing/2023/12/26/if-the-fed-lowers-interest-rates-in-2024-this-warr/?source=iedfolrf0000001
Dec 26, 2023 - Rising rates have been a headwind for Moody's bottom line.
0
Why CME Group Stock Was a Winner on Wednesday
https://www.fool.com/investing/2024/02/14/why-cme-group-stock-was-a-winner-on-wednesday/?source=iedfolrf0000001
Feb 14, 2024 - A rise in trading volume to a new annual record juiced the exchange operator's fundamentals.
0
Top Stock Reports for AbbVie, NIKE & BHP
https://www.zacks.com/commentary/2194633/top-stock-reports-for-abbvie-nike-bhp?cid=CS-ZC-FT-research_daily-2194633
Dec 07, 2023 - Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NIKE, Inc. (NKE) and BHP Group Ltd. (BHP).
0
2 Stocks to Watch as Ethereum Shows Promise for 2024
https://www.zacks.com/stock/news/2198508/2-stocks-to-watch-as-ethereum-shows-promise-for-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2198508
Dec 15, 2023 - Accenture (ACN) and CME are two Ethereum-exposed stocks that should be tracked as the bitcoin-rival promises a big 2024.
0
Down -7.96% in 4 Weeks, Here's Why CME (CME) Looks Ripe for a Turnaround
https://www.zacks.com/stock/news/2208237/down-7-96-in-4-weeks-here-s-why-cme-cme-looks-ripe-for-a-turnaround?cid=CS-ZC-FT-tale_of_the_tape|rsi-2208237
Jan 10, 2024 - CME (CME) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
0
Zacks Industry Outlook Highlights CME Group, Intercontinental Exchange, Cboe Global Markets, Coinbase Global and MarketAxess
https://www.zacks.com/stock/news/2209901/zacks-industry-outlook-highlights-cme-group-intercontinental-exchange-cboe-global-markets-coinbase-global-and-marketaxess?cid=CS-ZC-FT-press_releases-2209901
Jan 15, 2024 - CME Group, Intercontinental Exchange, Cboe Global Markets, Coinbase Global and MarketAxess have been highlighted in this Industry Outlook article.
0
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2210983/will-cme-cme-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2210983
Jan 16, 2024 - CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
What's in Store for Cboe Global (CBOE) This Earnings Season?
https://www.zacks.com/stock/news/2218837/what-s-in-store-for-cboe-global-cboe-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2218837
Jan 31, 2024 - Cboe Global's (CBOE) Q4 performance is likely to reflect improved transaction fees, increased demand for data and access solutions and strong proprietary products.
0
Page 1>